Related Videos
Advances (and Uncertainties) in Oncology: Current and Future Roles of Antibody Drug Conjugates
Focusing on common bladder, lung and breast cancers, three UCSF oncologists describe how antibody drug conjugates (ADCs) are changing the treatment landscape, especially for refractory cases
Breast Cancer Treatment Strategies: Experts Break Down the Latest
Reporting from the renowned San Antonio Breast Cancer Symposium, UCSF specialists present new research findings relevant to the complicated decisions made daily in designing treatment plans for individual patients.